iRhythm price target raised to $244 from $193 at Needham

Needham raised the firm’s price target on iRhythm (IRTC) to $244 from $193 and keeps a Buy rating on the shares. The company’s Q3 revenue beat consensus and management raised its 2025 revenue guidance by more than the beat, with the key drivers being Zio Monitor, further Zio AT penetration, and traction in the innovative channel, where iRhythm picked up a handful of new accounts, the analyst tells investors in a research note.